NCT03108989View on ClinicalTrials.gov

Comparison the Postoperative Quality of Recovery Between Neostigmine and Sugammadex in Elderly Patients Undergoing Trans Pars Plana Vitrectomy With General Anesthesia -Randomized Controlled Trial-

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

July 25, 2017

Study Completion Date

July 25, 2017

Conditions
Elderly Patients Undergoing Trans Pars Plana Vitrectomy With General Anesthesia
Interventions
DRUG

Sugammadex

After the end of surgery, sugammadex of 2 mg/kg will be administered to reverse neuromuscular blockade.

DRUG

Neostigmine

After the end of surgery, neostigmine will be administered to reverse neuromuscular blockade.

Trial Locations (1)

03722

Department of Anesthesiology and Pain Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03108989 - Comparison the Postoperative Quality of Recovery Between Neostigmine and Sugammadex in Elderly Patients Undergoing Trans Pars Plana Vitrectomy With General Anesthesia -Randomized Controlled Trial- | Biotech Hunter | Biotech Hunter